Modified bioluminescent enzymes
By developing novel bioluminescent enzymes and corresponding nucleic acid expression systems, the problems of insufficient photon yield and toxicity in existing bioluminescent pathways in plants, fungi, and mammalian hosts have been solved, enabling the application of autonomous bioluminescence and labeling tools.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NENGGUANG BIOTECHNOLOGY CO LTD
- Filing Date
- 2024-08-28
- Publication Date
- 2026-07-14
AI Technical Summary
Existing bioluminescence pathways have limited applications in plant, fungal, and mammalian hosts due to insufficient photon yield and toxicity issues, failing to meet the technical requirements of certain applications.
Develop novel bioluminescent enzymes, particularly trichoscin hydroxylase and luciferase and their functional fragments, to catalyze the conversion of trichoscin to 3-hydroxytrichoscin and its further oxidation to emit light, and combine them with nucleic acids encoding these enzymes and expression systems to achieve autonomous bioluminescence.
Autonomous bioluminescence in transgenic organisms was achieved without relying on exogenous luciferin, improving photon yield and overcoming toxicity issues, making it suitable as a labeling and reporting tool for multicellular organisms.
Smart Images

Figure CN122396765A_ABST